Clinical efficacy of leflunomide in the treatment of primary Sjogren's syndrome correlates with regulation of pro-inflammatory cytokines.

被引:0
|
作者
van Roon, Joel A. G. [1 ]
van Woerkom, Jan-Maarten [1 ]
Kruize, Aike A. [1 ]
Jacobs, Kim M. G. [1 ]
Bijlsma, Johannes W. J. [1 ]
Lafeber, Floris P. J. G. [1 ]
机构
[1] UMC Utrecht, Utrecht, Netherlands
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S256 / S256
页数:1
相关论文
共 50 条
  • [41] SPECIFIC T CELL AND B CELL DISTRIBUTIONS CHARACTERISE SUBGROUPS OF PATIENTS WITH PRIMARY SJOGREN'S SYNDROME AND ARE ASSOCIATED WITH DISEASE ACTIVITY AND PRO-INFLAMMATORY CYTOKINE EXPRESSION
    Le Lann, Lucas
    Simon, Quentin
    Jamin, Christophe
    Cornec, Divi
    Borghi, Maria-Oriette
    Beretta, Lorenzo
    Cervera, Ricard
    Saraux, Alain
    Lories, Rik
    Chizzolini, Carlo
    Alarcon-Riquelme, Marta
    Pers, Jacques-Olivier
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A54 - A54
  • [42] Specific T Cell and B Cell Distributions Characterize Subgroups of Patients with Primary Sjogren's Syndrome and Are Associated with Disease Activity and Pro-Inflammatory Cytokine Expression
    Le Lann, Lucas
    Simon, Quentin
    Jamin, Christophe
    Borghi, Maria Orietta
    Beretta, Lorenzo
    Cervera, Ricard
    Saraux, Alain
    Cornec, Divi
    Lories, Rik
    Chizzolini, Carlo
    Riquelme, Marta E. Alarcon
    Pers, Jacques-Olivier
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [43] Association of Severe Inflammatory Polyarthritis in Primary Sjogren's Syndrome: Clinical, Serologic, and HLA Analysis
    Mohammed, Khulood
    Pope, Janet
    Le Riche, Nicole
    Brintnell, William
    Cairns, Ewa
    Coles, Robert
    Bell, David A.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (09) : 1937 - 1942
  • [44] Hydroxychloroquine treatment for primary Sjogren's syndrome: its effect on salivary and serum inflammatory markers
    Tishler, M
    Yaron, I
    Shirazi, I
    Yaron, M
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (04) : 253 - 256
  • [45] Clinical Efficacy and Safety of Total Glucosides of Paeony for Primary Sjogren's Syndrome: A Systematic Review
    Jin, Liang
    Li, Chengyin
    Li, Yanping
    Wu, Bin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 2017
  • [46] Astaxanthin treatment decreases pro-inflammatory cytokines and improves reproductive outcomes in patients with polycystic ovary syndrome undergoing assisted reproductive technology: A randomized clinical trial
    Fereidouni, Farzane
    Kashani, Ladan
    Amidi, Fardin
    Khodarahmian, Mahshad
    Zhaeentan, Shahrzad
    Ardehjani, Negar Ajabi
    Rastegar, Tayebeh
    INFLAMMOPHARMACOLOGY, 2024, 32 (04) : 2337 - 2347
  • [47] Antiviral treatment cessation in HBeAg negative chronic hepatitis B: clinical outcome is associated with increase in specific pro-inflammatory cytokines
    Holmberg, Marte
    Reikvam, Dag Henrik
    Dalgard, Olav
    Aass, Hans Christian Dalsbotten
    Samuelsen, Ellen
    Bjorkstrom, Niklas
    Johannessen, Asgeir
    JOURNAL OF HEPATOLOGY, 2022, 77 : S826 - S827
  • [48] Low-Dose IL-2 Promotes the Proliferation of Peripheral Regulatory T Cells in Primary Sjogren's Syndrome to Restore Its Balances with Pro-Inflammatory Lymphocytes
    Miao, Miao
    Hao, Zhenye
    Guo, Yingying
    Zhang, Xiaoying
    Zhang, Sheng-Xiao
    Luo, Jing
    Zhao, Jinfang
    Gao, Chong
    Li, Xiao-Feng
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [49] Clinical efficacy of the smartplug™ in the treatment of primary Sjogren’s syndrome with keratoconjunctivitis SICCA: one-year follow-up study
    Sait Egrilmez
    Fatih Aslan
    Gonca Karabulut
    Yasemin Kabasakal
    Ayse Yagci
    Rheumatology International, 2011, 31 : 1567 - 1570
  • [50] Clinical efficacy of the smartplug™ in the treatment of primary Sjogren's syndrome with keratoconjunctivitis SICCA: one-year follow-up study
    Egrilmez, Sait
    Aslan, Fatih
    Karabulut, Gonca
    Kabasakal, Yasemin
    Yagci, Ayse
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (12) : 1567 - 1570